PHGDH-IN-5 free base · Synonyms: CPDP802335
PHGDH-IN-5 is a covalen inhibitor of PHGDH.
For research use only. Not for human or veterinary use.
PHGDH-IN-5 structure
CAS No.: 17402-86-7
Pack sizes & pricing
Description
PHGDH-IN-5 (Compound B12) is a covalen inhibitor of PHGDH with an IC50 value of 0.29 μM. PHGDH-IN-5 can inhibit cell proliferation in cancer cell lines overexpressing PHGDH. PHGDH-IN-5 can reduce the production of serine derived from glucose in MDA-MB-468 cells.
Biological activity
In Vitro PHGDH-IN-5 can inhibit the proliferation of MDA-MB-468, NCI-H1975, HT1080, and PC9 cells, with IC50 values ranging from 9.93 μM to 21.2 μM. PHGDH-IN-5 (10-30 μM) reduces the production of M+3-serine derived from 13C6-glucose in MDA-MB-468 cells[1].
Identifiers
- SMILES
-
O=S1(C2=CC=CC([N+]([O-])=O)=C2C=C1)=O - InChIKey
-
LWKOZDAODXAJCF-UHFFFAOYSA-N
Specifications
- MW (average)
- 211.1950
- Formula
- C8H5NO4S
- CAS No.
- 17402-86-7
- Physical state
- Solid
- Color
- Off-white to light yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month.
Solubility
Soluble in DMSO : 100 mg/mL
Documents
References
Same research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%